Calidi Biotherapeutics Inc. Gains 38.49%
Mon, Feb 03, 2025 at 07:31 PM
Calidi Biotherapeutics Inc. (CLDI:NYSEMKT) rocketted at $1.05, a gain of 38.5%. On Mon, Feb 03, 2025, CLDI:NYSEMKT touched a New 2-Week High of $1.05. The stock appeared on our News Catalysts scanner on Wed, Jan 29, 2025 at 08:21 AM in the 'MISCELLANEOUS' category. From Tue, Jan 21, 2025, the stock recorded 22.22% Up Days and 30.00% Green Days
The stock spiked on Wed, Nov 13, 2024 at $3.89 with a volume of 24M+.
About Calidi Biotherapeutics Inc. (CLDI:NYSEMKT)
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index.
Top 10 Gainers:
- Invivyd Inc. (IVVD:NASDAQ), 196.34%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 192.31%
- HCW Biologics Inc. (HCWB:NASDAQ), 128.58%
- MDJM LTD (UOKA:NASDAQ), 83.08%
- GH Research PLC (GHRS:NASDAQ), 69.72%
- Singularity Future Technology Ltd. (SGLY:NASDAQ), 65.34%
- Society Pass Incorporated (SOPA:NASDAQ), 59.87%
- Reborn Coffee Inc. (REBN:NASDAQ), 54.24%
- Calidi Biotherapeutics Inc. (CLDI:NYSEMKT), 38.49%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 35.71%